Selective inhibition by apocynin of the proliferation and adhesion to fibronectin of v-H-ras-transformed 3Y1 cells

Bioscience, Biotechnology and Biochemistry

Volumn 76, Issue 6, 2012, Pages 1177-1181

  Yamasaki, Masao ^a   Iwase, Masahiro ^a   Kawano, Kazuo ^a   Sakakibara, Yoichi ^a   Suiko, Masahito ^a   Nishiyama, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

1 Integrin; Fibronectin; H ras; Invasion; Reactive oxygen species

Indexed keywords

ABNORMAL GROWTH; ADHESIVE PROPERTIES; APOCYNIN; CELL SURFACE EXPRESSION; FIBRONECTIN; FIBRONECTIN-COATED PLATES; H-RAS; INVASION; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; SELECTIVE INHIBITION;

CELL ADHESION; CELL CULTURE; CELL MEMBRANES; OXYGEN;

ADHESION;

ACETOPHENONE DERIVATIVE; APOCYNIN; BETA1 INTEGRIN; ENZYME INHIBITOR; FIBRONECTIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL; ARTICLE; CELL ADHESION; CELL LINE; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; GENETIC TRANSFORMATION; GENETICS; METABOLISM; ONCOGENE RAS; PLASMID; RAT;

ACETOPHENONES; ANIMALS; ANTIGENS, CD29; CELL ADHESION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME INHIBITORS; FIBROBLASTS; FIBRONECTINS; GENES, RAS; NADPH OXIDASE; PLASMIDS; RATS; REACTIVE OXYGEN SPECIES; TRANSFORMATION, GENETIC;

EID: 84862734739     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.120061     Document Type: Article

References (30)

1. Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, Flanagan A, Teague J, Futreal PA, Stratton MR, and Wooster R, Br. J. Cancer, 91, 355-358 (2004).
2. Karnoub AE and Weinberg R, Nat. Rev. Mol. Cell Biol., 9, 517-531 (2008).
3. Schubbert S, Shannon K, and Bollag G, Nat. Rev. Cancer, 7, 295-308 (2007).
4. Lee J, Choi KJ, Lim MJ, Hong F, Choi TG, Tak E, Lee S, Kim YJ, Chang SG, Cho JM, Ha J, and Kim SS, Cell Res., 20, 919-934 (2010).
5. Choi JA, Kim EY, Song H, Kim C, and Kim JH, Free Radic. Biol. Med., 44, 624-634 (2008).
6. Liu R, Li B, and Qiu M, Oncogene, 20, 1486-1496 (2001).
7. Mitsushita J, Lambeth JD, and Kamata T, Cancer Res., 64, 3580-3585 (2004).
8. Shimura H, Mitsudomi T, Matsuzaki A, Kabemura M, Okuda A, and Kimura G, Cell Struct. Funct., 15, 211-219 (1990).
9. Zaitsu H, Tanaka H, Mitsudomi T, Matsuzaki A, Ohtsu M, and Kimura G, Biomed. Res., 9, 181-197 (1998).
10. Yamasaki M, Omi Y, Fujii N, Ozaki A, Nakama A, Sakakibara Y, Suiko M, and Nishiyama K, Biosci. Biotechnol. Biochem., 73, 2217-2221 (2009).
11. Desgrosellier JS and Cheresh DA, Nat. Rev. Cancer, 10, 9-22 (2010).
12. Yamasaki M, Iwase M, Kawano K, Sakakibara Y, Suiko M, and Nishiyama K, J. Clin. Biochem. Nutr., in press.
13. Deng T and Karin M, Nature, 371, 171-175 (1994).
14. Irani K, Xia Y, Zweier JL, Sollott SJ, der CJ, Fearon ER, Sundaresan M, Finkel T, and Goldschmidt-Clermont PJ, Science, 275, 1649-1652 (1997).
15. Takagi J, Strokovich K, Springer TA, and Walz T, EMBO J., 22, 4607-4615 (2003).
16. Wei Y, Czekay RP, Robillard L, Kugler MC, Zhang F, Kim KK, Xiong JP, Humphries MJ, and Chapman HA, J. Cell Biol., 168, 501-511 (2005).
17. Mori K, Shibanuma M, and Nose K, Cancer Res., 64, 7464-7472 (2004).
18. Cho SO, Kim KH, Yoon JH, and Kim H, Ann. NY Acad. Sci., 1090, 298-304 (2006).
19. Häuselmann SP, Rosc-Schlüter BI, Lorenz V, Plaisance I, Brink M, Pfister O, and Kuster GM, Free Radic. Biol. Med., 51, 609-618 (2011).
20. Flinder LI, Timofeeva OA, Rosseland CM, Wierød L, Huitfeldt HS, and Skarpen E, J. Cell. Physiol., 226, 2267-2277 (2011).
21. Wu WS, Cancer Metastasis, 25, 695-705 (2006).
22. Shin I, Kim S, Song H, Kim HR, and Moon A, J. Biol. Chem., 280, 14675-14683 (2005).
23. King SJ, Worth DC, Scales TM, Monypenny J, Jones GE, and Parsons M, EMBO J., 30, 1705-1718 (2011).
24. Davey G, Buzzai M, and Assoian RK, J. Cell Sci., 112, 4663-4672 (1999).
25. Kuwada SK and Li X, Mol. Biol. Cell, 11, 2485-2496 (2000).
26. Stefanska J and Pawllczak R, Med. Inflamm., 2008, 1-10 (2008).
27. Engels F, Renirie BF, Hart BA, Labadie RP, and Nijkamp FP, FEBS Lett., 305, 254-256 (1992).
28. Bysani GK, Kennedy TP, Ky N, Rao NV, Blaze CA, and Hoidal JR, J. Clin. Invest., 86, 1434-1441 (1990).
29. Ekambaram P, Lambiv W, Cazzolli R, Ashton AW, and Honn KV, Cancer Metastasis Rev., 30, 397-408 (2011).
30. Jiang JG, Ning YG, Chen C, Ma D, Liu ZJ, Yang S, Zhou J, Xiao X, Zhang XA, Edin ML, Card JW, Wang J, Zeldin DC, and Wang DW, Cancer Res., 67, 6665-6674 (2007).